Paper
- Alzforum Recommends
Brelstaff JH, Mason M, Katsinelos T, McEwan WA, Ghetti B, Tolkovsky AM, Spillantini MG. Microglia become hypofunctional and release metalloproteases and tau seeds when phagocytosing live neurons with P301S tau aggregates. Sci Adv. 2021 Oct 22;7(43):eabg4980. Epub 2021 Oct 20 PubMed.
Recommends
Please login to recommend the paper.
Comments
Mayo Clinic Florida
This interesting paper is novel in discovering the change of microglia after phagocytosis of pathogenic tau into a senescent phenotype, and in demonstrating their role in seeding tau aggregates after phagocytosis of tau-containing neurons. The study will shed new light for our understanding of tau propagation in glia and non-synaptic mechanism.
We have previously published a hypothesis proposing a role of microglia for disseminating tau-containing extracellular vesicles after phagocytosis of tau-containing neurons (Delpech et al., 2019, Figure 2). We also observed secretion of tau aggregates as free form after microglial phagocytosis.
In terms of microglial senescence, it is difficult to distinguish inflammatory activation and senescence, since activated microglia are both phagocytic and inflammatory and are known to secrete inflammatory molecules including MMPs. More relevant markers, such as expression of p16/CDKN2A or DNA damage, are more convincing for the evaluation of cellular senescence.
References:
Delpech JC, Herron S, Botros MB, Ikezu T. Neuroimmune Crosstalk through Extracellular Vesicles in Health and Disease. Trends Neurosci. 2019 May;42(5):361-372. Epub 2019 Mar 26 PubMed.
View all comments by Tsuneya IkezuUniversity of Southampton
This article nicely links the phagocytosis of pathological tau material with the engagement of microglia in a senescence-like phenotype, which is informative to understand the long-term consequences of microglia being exposed to tau.
A number of experiments are performed in vitro. One should be cautious about extrapolating in vitro mechanisms to the in vivo condition. It is well established that cultured microglia differ quite significantly from the microglia that we can find in the living brain, in terms of phenotype, motility, as well as phagocytic capacity.
The in vitro paradigm is also challenging when understanding, and defining, what a “live” neuron is, versus what a “dead” neuron is, versus all the shades of gray in between. The data presented in this article indicates neurons are expressing PtdSer on their membranes; that should be seen as an indication of a compromised neuron (let’s say, in critical care), and not a healthy neuron. I believe this is an important consideration when studying whether microglia can eat alive, healthy neurons; so far the literature indicates that that is a rather rare phenomenon.
The data indicating the seeding ability of the tau secreted by microglia is interesting, and serves a strong independent validation of the data reported in Asai et al. (2015). Checking for presence of exosomes containing tau would be a useful follow-up.
The data generated in slice cultures suggests that microglia have an impaired phagocytic capacity, which, in turn, coexists with a senescent phenotype. These results validate findings reported in Bussian et al. (2018). Collectively, they suggest tau is strongly linked to an induction of senescence in microglia, and add to the evidence from our group indicating that Aβ pathology also is associated with microglial senescence (Hu et al., 2021).
The link of tau-dependent microglial senescence and reduced phagocytosis still lacks a direct mechanistic experiment differentiating association from causation: Is senescence triggered first and lead to defective phagocytosis, or is the indigestion caused by ove- phagocytosis of tau, leading to senescence? How widespread is this phenotype within the microglial population? Does it depend on the specific tau species/model?
In sum, clearly the study of microglial senescence in Alzheimer’s pathology is offering new insights on how these cells interact with the pathological components of the disease, and generate insight into the long-term consequences of chronic microglial activation.
References:
Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, Wolozin B, Butovsky O, Kügler S, Ikezu T. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015 Nov;18(11):1584-93. Epub 2015 Oct 5 PubMed.
Bussian TJ, Aziz A, Meyer CF, Swenson BL, van Deursen JM, Baker DJ. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature. 2018 Oct;562(7728):578-582. Epub 2018 Sep 19 PubMed.
Hu Y, Fryatt GL, Ghorbani M, Obst J, Menassa DA, Martin-Estebane M, Muntslag TA, Olmos-Alonso A, Guerrero-Carrasco M, Thomas D, Cragg MS, Gomez-Nicola D. Replicative senescence dictates the emergence of disease-associated microglia and contributes to Aβ pathology. Cell Rep. 2021 Jun 8;35(10):109228. PubMed.
View all comments by Diego Gómez-NicolaUniversity of New Mexico
This is a very interesting paper. The model system is quite novel, the experiments are rigorous. The senescence onset and hypophagocytic phenotype of 5M P301L DRGn engulfed microglia is compelling. That these microglia are still capable of activating NFκB and actively secreting tau seeds, despite undergoing two functionally deficient phenotypes (senescence and hypophagocytic), is very perplexing. We have recently (Jiang et al., 2021) observed that neurofibrillary tangles derived from human AD brains are capable of increasing the expression of various members of the NFκB family, including NFKB1A, in human primary microglia, and of inducing NFκB activation via an MyD88-dependent pathway. This nicely complements the observations made by here.
Related to the cytokine array analyses, it would be interesting to use genome-wide RNA-Seq in post-DRGn microglia (besides assaying for selected proteins) to determine if they show other functional/canonical pathway(s) related to innate immunity etc., and if any of them belong to DAM subtypes.
Furthermore, there are some interesting trends in the datasets, which may need further investigation or clarification. For example, the LDH assay did not show evidence for cell death of tau aggregate-containing DRGns, suggesting that tau seeds released were not due to death of tau aggregate-containing DRGns. However, annexin V treatment prevented the death of these neurons. That means it is possible that some amount of tau is still released due to cell death. The importance of MMP-3 in the senescent microglia could explain their role in the chronic inflammation seen in dementia, where MMP-3 appears in the cerebrospinal fluid and brain tissue.
Overall, this study nicely extends our understanding of the phenotype of microglia upon engulfment of tau containing neurons.
— Gary Rosenberg is a co-author of this comment.
References:
Jiang S, Maphis NM, Binder J, Chisholm D, Weston L, Duran W, Peterson C, Zimmerman A, Mandell MA, Jett SD, Bigio E, Geula C, Mellios N, Weick JP, Rosenberg GA, Latz E, Heneka MT, Bhaskar K. Proteopathic tau primes and activates interleukin-1β via myeloid-cell-specific MyD88- and NLRP3-ASC-inflammasome pathway. Cell Rep. 2021 Sep 21;36(12):109720. PubMed.
View all comments by Kiran BhaskarGerman Center for Neurodegenerative Diseases (DZNE)
Evidence from the past years showed that microglia participate in tau spread (Asai et al., 2015), and that senescent glia cells are implicated in tau pathology (Bussian et al., 2018). This new study expands our knowledge on this topic and adds some interesting new functional aspects.
The authors show that microglia that phagocytose tau aggregate-bearing neurons release seed-competent insoluble tau. Interestingly, co-culture with tau-positive neurons drives microglia into a senescent-like state characterized by a senescence-associated secretory profile (SASP) with a lower phagocytosis rate. Using tau-positive neurons similar to those in their previous study (Brelstaff et al., 2018) is an elegant way of investigating the impact of tau pathologies on microglia and how the microglia response can feed back to the neurons.
The important results presented here raise interesting questions. For one, it will be important to identify the driving force that leads to the senescence-like phenotype, and to investigate if this is independent of the phagocytosis of neurons.
In addition, the data suggest that the reduced phagocytic activity of microglia is independent of the presence of tau. But it remains unclear if the hypophagic phenotype develops only upon ingestion of the neurons or if it is mediated via a neuronal-secreted factor in a paracrine fashion. Investigating this in the future will be important to find potential new treatment targets. The work by Jack Brelstaff and colleagues provides the basis for analyzing this on a translational trajectory.
References:
Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, Wolozin B, Butovsky O, Kügler S, Ikezu T. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015 Nov;18(11):1584-93. Epub 2015 Oct 5 PubMed.
Bussian TJ, Aziz A, Meyer CF, Swenson BL, van Deursen JM, Baker DJ. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature. 2018 Oct;562(7728):578-582. Epub 2018 Sep 19 PubMed.
Brelstaff J, Tolkovsky AM, Ghetti B, Goedert M, Spillantini MG. Living Neurons with Tau Filaments Aberrantly Expose Phosphatidylserine and Are Phagocytosed by Microglia. Cell Rep. 2018 Aug 21;24(8):1939-1948.e4. PubMed.
View all comments by Christina IsingUC, Irvine
Interestingly, in 1996 Frederick Maxfield’s group reported somewhat similar results for microglia and fibrillar Aβ.
From their abstract: They examined the uptake, degradation, and release of small aggregates of fibrillar Aβ (fAβ) or soluble Aβ (sAβ) by microglia. They found that although some degradation of fAβ was observed over three days, no further degradation was observed over the next nine days. Instead, there was a slow release of intact Aβ. However, the poor degradation was not due to inhibition of lysosomal function, since the rate of α2-macroglobulin degradation was unaffected by the presence of fAβ in the late endosomes or lysosomes.
Finally, the authors showed that while microglia internalize a large fraction of fAβ and sAβ, both are released without much degradation (Chung et al., 1999).
References:
Chung H, Brazil MI, Soe TT, Maxfield FR. Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells. J Biol Chem. 1999 Nov 5;274(45):32301-8. PubMed.
View all comments by David CribbsMake a Comment
To make a comment you must login or register.